Kairos Pharma Ltd. (NYSE: KAPA)
Develops immunotherapeutic drugs for cancer patients that reverse tumor-induced immune suppression.
Aims to improve clinical outcomes while preserving patient quality of life.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
